文献速递胸部肿瘤

低剂量CT肺癌筛查对死亡率影响的系统综述与荟萃分析

Systematic review and meta-analysis on the impact of lung cancer screening by low-dose computed tomography.
PubMed 文献 · Eur J Cancer · 2020-06-02

该系统综述与荟萃分析纳入7项随机对照试验共84558名吸烟史超过15包年的参与者,比较低剂量CT筛查与任何其他干预。结果显示筛查组肺癌特异性死亡率相对降低17%(RR=0.83,95%CI:0.76-0.91),总死亡率相对降低4%(RR=0.96,95%CI:0.92-1.00)。结论为在烟草高暴露人群中低剂量CT筛查可降低肺癌死亡率。

要点

  • 在吸烟史>15包年人群中,低剂量CT筛查使肺癌死亡率相对降低17%。
  • 低剂量CT筛查使总死亡率相对降低4%,95%CI上限为1.00。
  • 纳入7项RCT共84558人,支持对烟草高暴露人群进行LDCT筛查。

核心结论

  • 在烟草高暴露人群中,低剂量CT筛查可降低肺癌死亡率。

研究设计与样本

  • 系统综述与荟萃分析,检索Medline和Cochrane Library从建库至2018年2月19日的随机对照试验。
  • 纳入7项RCT,共84558名报告平均吸烟史大于15包年的参与者,比较LDCT筛查与任何其他干预。
  • 文献筛选和数据提取由两名双盲评价者独立完成。

主要发现

  • 筛查组相比对照组肺癌特异性死亡率相对降低17%(RR=0.83,95%CI:0.76-0.91)。
  • 筛查组相比对照组总死亡率相对降低4%(RR=0.96,95%CI:0.92-1.00)。

关键数值与推荐

  • 纳入标准为报告平均吸烟史大于15包年的人群,干预为LDCT筛查对比任何其他干预。
  • 肺癌死亡率风险比RR=0.83(95%CI:0.76-0.91),总死亡率RR=0.96(95%CI:0.92-1.00)。

临床怎么用

  • 对吸烟史超过15包年的高暴露人群,可考虑采用低剂量CT进行肺癌筛查以降低肺癌死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lung cancer (LC) has the highest cancer mortality worldwide with poor prognosis. Screening with low-dose computed tomography (LDCT) in populations highly exposed to tobacco has been proposed to improve LC prognosis. Our objective was to perform a systematic review and meta-analysis to evaluate the efficacy of screening by LDCT compared with any other intervention in populations who reported tobacco consumption for more than 15 years on LC and overall mortality. METHODS: We searched randomised controlled trials (RCTs) studying screening by LDCT compared with any other intervention in a population who reported an average smoking history greater than 15 pack-years from inception until the 19th February 2018 using Medline and Cochrane Library databases. Publication selection and data extraction were made independently by two double-blind reviewers. RESULTS: Seven RCTs were included in the meta-analysis which corresponds to 84,558 participants. A significant relative reduction of LC-specific mortality of 17% (risk ratio [RR] = 0.83, 95% confidence interval [CI]: 0.76-0.91) and a relative reduction of overall mortality of 4% (RR = 0.96, 95% CI: 0.92-1.00) was observed in the screening group compared with the control group. CONCLUSION: In populations highly exposed to tobacco, screening by LDCT reduces lung cancer mortality.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Sadate A, Occean BV, Beregi JP, et al. Systematic review and meta-analysis on the impact of lung cancer screening by low-dose computed tomography. Eur J Cancer. 2020. PMID: 32502939. doi:10.1016/j.ejca.2020.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。